{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Mitomycin_A",
  "nciThesaurus": {
    "casRegistry": "4055-39-4",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus.  Bioreduced mitomycin A generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis.  Mitomycin A is more toxic than mitomycin C due to increased and nonselective DNA cross-linking in both aerobic and hypoxic cells.",
    "fdaUniiCode": "87TMG6FJHV",
    "identifier": "C1164",
    "preferredName": "Mitomycin A",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C663"
    ],
    "synonyms": [
      "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-6,8a-dimethoxy-5-methyl-, carbamate (ester)",
      "MITOMYCIN A",
      "Mitomycin A"
    ]
  }
}